Inventor · disambiguated record
Pawel Wojciech Nowak
Also filed as: NOWAK PAWEL W · NOWAK PAWEL WOJCIECH
32 granted patents·13 pending applications·44 citations·filing 2006–2022
96Inventor score
Top patents by PatentIndex Score
45 records- 0193US9353122B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·14 cites·50 claims
- 0287US9877970B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·4 cites·26 claims
- 0387US9580421B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·4 cites·20 claims
- 0486US10398703B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Sep 3, 2019·3 cites·26 claims
- 0585US10758539B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·1 cites·23 claims
- 0683US9861634B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 9, 2018·2 cites·21 claims
- 0783US9353123B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·3 cites·35 claims
- 0882US9827248B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·2 cites·21 claims
- 0982US9212145B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Dec 15, 2015·3 cites·80 claims
- 1081US10392388B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·2 cites·38 claims
- 1181US2023116686A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1280US9988386B2Compounds for treatment of diseases of abnormal angiogenesis or aberrant growth factors and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 5, 2018·3 cites·23 claims
- 1379US10059693B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·29 claims
- 1479US10059692B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·31 claims
- 1578US9802922B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Oct 31, 2017·1 cites·12 claims
- 1674US11369611B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·0 cites·9 claims
- 1774US11352343B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 1874US11091487B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·22 claims
- 1974US2021393641A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2072US10966987B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·21 claims
- 2172US2021380588A1Novel Compounds and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2271US10723719B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·20 claims
- 2371US2021332048A1Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2469US10954244B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 2568US10329280B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·20 claims
- 2668US10316022B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·18 claims
- 2768US10285991B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·0 cites·26 claims
- 2867US10875857B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·0 cites·15 claims
- 2967US10351570B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jul 16, 2019·0 cites·25 claims
- 3067US2021087192A11-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3163US10544151B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·0 cites·46 claims
- 3263US9833453B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Dec 5, 2017·0 cites·25 claims
- 3362US9725451B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·0 cites·67 claims
- 3461US10174022B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Jan 8, 2019·0 cites·9 claims
- 3560US11401260B2Biochemical binding of RET9 and VEGFR2 inhibitorsKALA PHARMACEUTICALS INC·Filed 2018·Granted Aug 2, 2022·0 cites·8 claims
- 3660US2009253716A1Amino-imidazolones for the inhibition of beta-secretaseMALAMAS MICHAEL SOTIRIOS·Filed 2009·Application pending·0 cites
- 3755US9695184B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jul 4, 2017·0 cites·39 claims
- 3853US2010015141A14-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 3952US7563796B2Diphenylimidazopyrimidines as inhibitors of β-secretaseWYETH CORP·Filed 2006·Granted Jul 21, 2009·0 cites·16 claims
- 4049US2010068204A14-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agentsWYETH CORP·Filed 2009·Application pending·0 cites
- 4148US2009311217A13-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 4248US2008234262A1Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 4347US2008233127A1Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 4445US2007191431A12-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulationWYETH CORP·Filed 2006·Application pending·0 cites
- 4544US2007027199A1Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulationWYETH CORP·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pawel Wojciech Nowak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →